Medical Device Definition and Scope Under Belarus Resolution No. 211

1. Key takeaways

Belarusian regulatory instruments use three terms side by side, and the outcome of defining a product under them directly determines whether state registration is required. The very title of Resolution No. 211 places the three together: On State Registration (Re-registration) of Medical Devices (Medical Articles, Medical Equipment). The first step in judging whether a product falls within the registration scope is definition, not a catalogue search.

2. Legal basis

3. Expert insights

Insight 1: the change in the wording of the title is itself information. The title of the old resolution № 1269 read only medical articles and medical equipment (изделий медицинского назначения и медицинской техники), while the title of the new resolution № 211 became medical devices (medical articles, medical equipment) (медицинских изделий (изделий медицинского назначения, медицинской техники)) — elevating medical devices to the umbrella term and demoting the other two to an explanatory bracket. This shift in wording converges with the phrasing of the union agreement and is a linguistic signal that Belarus is moving toward the union’s terminology.

Insight 2: when the definition is unclear, an official confirmation channel exists. The list of services of the body includes one item: issuing a conclusion that a product intended for import (or being imported) is a medical device, medical equipment, or a raw material or component for their production, for use in VAT exemption and in confirming the purpose of the goods (determination of customs tariff rates). Where a product’s status is disputed, a company can obtain a written conclusion through this channel rather than judging on its own.

Insight 3: the outcome of the definition spills over into tax and customs. The same conclusion is used both for VAT exemption and for determining tariff rates, which shows that whether something is a medical device in Belarus is not only a regulatory question but also a tax question. A definitional error is magnified across three stages at once: registration, taxation and customs clearance.

Insight 4: accessories and components need separate confirmation. Where a component can be sold separately and also forms part of another device, whether it requires separate registration depends on whether it circulates on its own. This judgment should be confirmed in writing with a local representative at the project start stage.

Insight 5: keep the three terms distinct when preparing documents. Because the title of № 211 treats medical devices as the umbrella term and medical articles and medical equipment as its components, application forms, service conclusions and internal master data should record which term a product falls under rather than merge them into one label. The old № 1269 title used only the two narrower terms, so legacy dossiers may describe the same product differently from the new regime. Where an entry in a legacy document does not match the current three-term structure, align the wording before submission to avoid unnecessary clarifications during the preliminary technical work.

4. Practical recommendations

1. Define before searching the catalogue. First judge the product’s status against the definition and intended use, then search the classification catalogue; reversing the order leads to the mistaken conclusion that a product absent from the catalogue needs no registration.
2. Route status disputes through official confirmation. For borderline products, request the body to issue a conclusion on purpose and status, and obtain the written document before starting registration preparation.
3. Assess tax consequences in parallel. The definitional conclusion affects VAT and customs treatment, so align the interpretation with the customs broker already at the registration planning stage.
4. Evaluate separately sold accessories separately. Do not treat the device being registered as automatically exempting its accessories from registration.

5. Verification checklist

• □ Product status defined under the three-term approach of the № 211 title
• □ Official written conclusion requested where the status is disputed
• □ Effect of the definitional conclusion on VAT and customs assessed in parallel
• □ Separately circulating accessories evaluated separately for registration needs
• □ Definitional conclusion documented in writing and attached to the registration materials

Regulatory information verified as of 2026-10-30.

In the Eurasian Economic Union market, GRZAN concentrates its core capabilities in three areas. First, distinguishing between the union-wide registration route and each member state’s national registration route — their applicable conditions and remaining time windows. The national registration procedure of Belarus has been fully replaced by Council of Ministers Resolution No. 211 of 28 April 2026 (state registration number 6-1/55925, effective 1 May 2026), which caps the total duration of preliminary technical work at 90 calendar days, keeps the list of that work closed and prohibits the organizing body from expanding it, while the window for filing applications under the national procedure has 31 December 2027 as its key date, so the choice of route must be made in step with the time window. Second, local authorized representative services: GRZAN may act as the manufacturer’s statutory representative in Belarus, undertaking registration submissions, responses to technical queries, changes to the registration dossier and post-market reporting obligations, and it has updated its liaison arrangements after Council of Ministers Resolution No. 378 of 27 July 2026 (effective 30 July 2026) transferred the adverse-event functions to the State Institution State Medical Products Supervision (Gosfarmnadzor). Third, quality system and testing support: GRZAN assists in establishing a quality management system that meets ISO 13485 requirements and in organizing technical documentation for the chosen route — the national route follows the annexes to Ministry of Health Resolution No. 55, and the union route follows Decision No. 46 of the Board of the Eurasian Economic Commission.

Business inquiries: info@grzanglobal.com